PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

J-Pharma Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (9)

J-Pharma Co., Ltd. made a loss over the last year. J-Pharma Co., Ltd. owes ¥0.21 for every ¥1 it owns. J-Pharma Co., Ltd. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Mar 2025.

P/E ratio

Loss

J-Pharma Co., Ltd. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

3.44

The share price is 3.44 times J-Pharma Co., Ltd.'s book value per share, higher than 82% of Healthcare companies in Japan.

Market cap

¥8.1 B

The total market value of all of J-Pharma Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 66% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥2.3 B

What J-Pharma Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Dec 2025).

Book value per share

¥130.37

Net worth divided by the number of shares. The share price of ¥449.00 is 3.4 times this, which is the P/B above.

Return on equity (ROE)

-73.0%

J-Pharma Co., Ltd. lost 73.0% of its shareholders' money over the last year, lower than 94% of Healthcare companies in Japan.

Owes vs Owns

0.21×

J-Pharma Co., Ltd. owes ¥0.21 for every ¥1 it owns (low), lower than 74% of Healthcare companies in Japan.

Dividend yield

None

J-Pharma Co., Ltd. does not currently pay a dividend.

Profit growth

Loss

J-Pharma Co., Ltd. made a loss in each of the last two years.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For J-Pharma Co., Ltd.: ¥8.1 B ÷ ¥2.3 B (31 Dec 2025) = 3.4.

What is J-Pharma Co., Ltd.'s return on equity?

J-Pharma Co., Ltd. lost 73.0% of its shareholders' money over the last year, lower than 94% of Healthcare companies in Japan.

How much does J-Pharma Co., Ltd. owe compared with what it owns?

J-Pharma Co., Ltd. owes ¥0.21 for every ¥1 it owns (low), lower than 74% of Healthcare companies in Japan.

Does J-Pharma Co., Ltd. pay a dividend?

No. J-Pharma Co., Ltd. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.